In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), Jubilant Life Sciences has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, July 27, 2018, to consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2018.
The above information is a part of company’s filings submitted to BSE.